Previously, we reported that 6,7-dimethoxy-3-(3-methoxyphenyl) isoquinolin-1-amine (CWJ-082) has potent cytotoxic effects on various cancer cells, but the underlying molecular mechanism responsible was not determined. In the present study, CWJ-082 caused cervical cancer cell cycle arrest at the G 2 /M phase and subsequent caspase-dependent apoptosis. The mitotic arrest caused by CWJ-082 found to be due to increases in the activation of cyclin-dependent kinase 1/cyclin B1 complex and the phosphorylation of histone H3. In addition, CWJ-082 induced the phosphorylation of BubR1 and the association between mitotic arrest deficient 2 (Mad2) and cell division cycle protein 20. These findings suggested that CWJ-082 activated the mitotic spindle checkpoint. Furthermore, knockdown of the spindle checkpoint proteins BubR1 or Mad2 using specific small interfering RNAs significantly reduced CWJ-082-induced mitotic cell accumulation and apoptosis. In addition, CWJ-082 induced the appearance of spindle abnormalities by inducing α-tubulin polymerization. In BALB/c nu/nu mice bearing a HeLa xenograft, CWJ-082 significantly inhibited tumor growth. Taken together, these results suggest that CWJ-082 inhibits cell growth via mitotic arrest by activating the mitotic spindle checkpoint and by inducing α-tubulin polymerization and that these events ultimately lead to the apoptosis of human cervical cancer cells and inhibit tumor growth in HeLa xenograft mice.
Introduction
Chemicals that interfere with cell cycle progress have attracted much attention in cancer research because they can inhibit the proliferation of cancer cells. Of the various anticancer drug targets identified to date, those targeting microtubules are among the most successful cancer therapeutics (1) . Microtubules, which are composed of α-and β-tubulin dimers, are one of the most useful subcellular targets in chemotherapy and are key components of the mitotic spindle and essential for chromosome segregation during eukaryotic cell division (2) . Microtubule ends undergo stochastic switching between a polymerized state and a depolymerized state under the control of numerous spindle-related regulators. A large body of evidence indicates that microtubule-targeting agents are effective anticancer drugs because they interfere with the dynamics of mitotic spindles and subsequently cause cell cycle arrest and ultimately cancer cell death (3). There are two major groups of antimitotic agents, namely, microtubule-stabilizing agents (taxanes, epothilones and discodermolide) and microtubule-destabilizing drugs (vinca alkaloids and colchicines). Tubulin-binding agents alter the dynamic behaviors of microtubules and arrest mitotic cells in the mitotic phase of the cell cycle and thus lead to apoptotic cell death (4) .
The spindle assembly checkpoint (SAC) arrests cells in mitosis to prevent unequal segregation of chromosomes during cell division. Activation of the checkpoint is signaled by a lack of microtubulekinetochore attachment or improper tension imposed on sister kinetochores (5) . The mechanism of mitotic spindle checkpoint-mediated arrest involves inhibition of the anaphase-promoting complex/cyclosome (APC/C), a ubiquitin ligase responsible for directing the ubiquitination and resulting proteolysis of securin and cyclin B. Securin inhibits separase, a protease that cleaves the cohesin complexes, which holds sister chromatids together. Furthermore, the proteolysis of securin is necessary for anaphase (6) , and the proteolysis of cyclin B, which directs the activity of cyclin-dependent kinase 1 (CDK1), the master mitotic kinase, is necessary for mitotic exit (7) . Activation of the spindle checkpoint involves the formation of the mitotic checkpoint complex, which comprises mitotic arrest deficient 2 (Mad2), budding uninhibited by benzimidazole 1 (Bub1) and a hybrid of Mad3 and Bub1 (BubR1) (5) . In addition, the interaction between mitotic checkpoint complex and cell division cycle protein 20 (CDC20), a subunit of the APC/C, inhibits the APC/C-mediated ubiquitinations of securin and cyclin B (8) .
Isoquinolines and structurally related compounds are an important class of biologically and medicinally useful agents. Many isoquinolines have been reported to possess diverse biological effects, including anti-inflammatory, antitumor and antimalarial effects (9, 10) . In particular, isoquinolines have attracted research interest as potential anticancer agents due to their inhibitions of topoisomerase I activity (11) (12) (13) . For example, benzo[c]phenanthridine derivatives have been found to possess great antiproliferative activity in various cancer cells (14) (15) (16) . Furthermore, NK314, a novel benzo[c]phenanthridone, was found to inhibit topoisomerase IIα and G 2 cell cycle arrest (15) . In our continued efforts to discover novel compounds with potent antitumor activity, we designed and synthesized a library of novel 3-arylisoquinoline derivatives and found that 6,7-dimethoxy-3-(3-methoxyphenyl)isoquinolin-1-amine (CWJ-082) possesses potent cytotoxic activity against HeLa cells via the induction of apoptosis (17) . In the present study, we examined the molecular mechanisms underlying the proapoptotic activities of CWJ-082 in HeLa human cervical cancer cells and in BALB/c nu/nu mice bearing a HeLa xenograft. Importantly, CWJ-082 potentially represents a novel class of cell cycle pathway-targeting and microtubule-targeting agents for cancer therapy. Figure 1A ) was prepared as described previously (17) . RPMI 1640 medium, fetal bovine serum, penicillin and streptomycin were obtained from Life Technologies (Grand Island, NY). 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT), dimethyl sulfoxide, RNase A, phenylmethylsulfonylfluoride, Triton X-100, propidium iodide (PI), Nonidet Abbreviations: APC/C, anaphase-promoting complex/cyclosome; CDC20, cell division cycle protein 20; CDK1, cyclin-dependent kinase 1; CWJ-082, 6,7-dimethoxy-3-(3-methoxyphenyl)isoquinolin-1-amine; FITC, fluorescein isothiocyanate; Mad2, mitotic arrest deficient 2; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide; NP-40, Nonidet P-40; PARP-1, poly(ADP-ribose) polymerase-1; PBS, phosphate-buffered saline; p-histone H3, phospho-histone H3; PI, propidium iodide; RIPA, radioimmunoprecipitation assay; SAC, spindle assembly checkpoint; SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis; siRNA, small interfering RNA. The enzymatic activities of caspase-3, -8 and -9 were induced by CWJ-082 in HeLa cells. Cells were treated with CWJ-082 (50-500 nM for 48 h) and then harvested. The enzymatic activities of caspases induced by CWJ-082 were assayed using a colorimetric assay. (D) HeLa cells were pretreated with 50 μM z-VAD-fmk for 1 h and then treated with or without CWJ-082 (300 nM for 48 h). Cells were costained with PI and FITC-conjugated annexin V, and the translocation of phosphatidylserine was detected by flow cytometry after CWJ-082 treatment. (E) HeLa cells were treated with or without CWJ-082 (300 nM) for the indicated times and then harvested. The expression levels of proteins were determined by western blotting using β-actin as the internal control. Relative intensities of p-Bcl-2 and cleaved PARP-1 bands were normalized versus β-actin. Experiments were repeated three times and similar results were obtained. Densitometric analysis was performed using Bio-Rad Quantity One® Software. The data shown represent means ± SD of three independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001 versus control group and † † † P < 0.001 versus CWJ-082-treated group. P-40 (NP-40), protein inhibitor cocktail, paclitaxel and nocodazole were purchased from Sigma Chemical Co. (St Louis, MO). Antibodies for anticyclin B (GNS1), anti-poly(ADP-ribose) polymerase-1 [PARP-1 (F-2)], anti-α-tubulin (B-7), anti-Mad2 (C-19), anti-BubR1 (8G1) and anti-β-actin (ACTBD11B7) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Antibodies for anti-phospho-Bcl-2, anti-phospho-histone H3, antiphospho-CDK1 (Tyr15), anti-phospho-CDK1 (Thr161), anti-CDK1 and anti-CDC20 (AR12) were purchased from Cell Signaling Technology (Beverly, MA). Fluorescein isothiocyanate (FITC)-conjugated annexin V was purchased from BD Biosciences-Pharmingen (San Diego, CA) and PureProteome™ protein A magnetic beads were purchased from Millipore (Billerica, MA).
Material and methods

Materials
CWJ-082 (
Cell culture and MTT assays
HeLa (human cervical adenocarcinoma), Caski (human cervical adenocarcinoma), A549 (human lung adenocarcinoma), A172 (human glioblastoma) and SKOV-3 (human ovarian adenocarcinoma) were obtained from the Korean Cell Line Bank (Seoul, Korea) and Ect/E6/E7 (human ectocervical epithelial) was obtained from the American Type Culture Collection (Manassas, VA). A2780 (human ovarian carcinoma) was kindly provided by Dr Ie-Ming Shih (Johns Hopkins School of Medicine, Baltimore, MD). Cells were cultured in RPMI 1640 or Dulbecco's modified Eagle's minimum essential medium supplemented with 10% heat-inactivated fetal bovine serum, penicillin (100 U/ml) and streptomycin sulfate (100 µg/ml) (Life Technologies). Cells were cultured at 37°C in an atmosphere of 5% CO 2 in the presence or absence of the CWJ-082. The cytotoxicity was assessed using a MTT assay. Briefly, the cells (5 × 10 4 ) were seeded in each well containing 100 µl of the RPMI medium supplemented with 10% fetal bovine serum in a 96-well plate. After 24 h, various concentrations of the CWJ-082 were added. After 48 h, 50 µl of MTT (5 mg/ml stock solution) was added and the plates were incubated for an additional 4 h. The medium was discarded and the formazan blue, which was formed in the cells, was dissolved with 100 µl dimethyl sulfoxide. The optical density was measured at 540 nm.
Analysis of cell cycle progression and mitotic index
Cell cycle progression was monitored using DNA flow cytometry. DNA was stained with PI, and mitotic cells were quantified by measuring the expression of a mitosis-specific marker, phospho-histone H3 (p-histone H3) (18) . In brief, the cells were trypsinized, washed once with phosphate-buffered saline (PBS) (pH 7.4), fixed with ice-cold 70% ethanol for 16 h and immunostained with a mouse anti-p-histone H3 antibody (Cell Signaling Technology) followed by a FITC-conjugated goat anti-mouse antibody (Jackson Immuno Research Laboratories, West Grove, PA). The cells were then stained with 4 μg/ml PI in PBS containing 1% Triton X-100 and 0.1 mg/ml RNase A. p-Histone H3 levels and the DNA content of individual cells were analyzed using a fluorescence-activated cell sorting cater-plus flow cytometry (Becton Dickinson Co., Heidelberg, Germany).
Determination of caspase activity
The enzymatic activity of the caspases induced by CWJ-082 was assayed using a colorimetric assay kit (Calbiochem, Bad Soden, Germany) according to the manufacturer's protocol. Briefly, the cells were harvested and lysed in a lysis buffer for 5 min on an ice bath. The lysed cells were centrifuged at 10 000g for 10 min, and 10 μg of the protein was incubated with 80 μl of an assay buffer and 10 μl of the substrate, respectively, at 37°C for 2 h. The optical density of the reaction mixture was quantified spectrophotometrically at a wavelength of 405 nm.
Annexin V and PI double staining by flow cytometry
During apoptosis, exposure of phosphatidylserine on the exterior surface of the plasma membrane can be detected by the binding of fluoresceinated annexin V (annexin V-FITC). This assay is combined with analysis of the exclusion of the plasma membrane integrity probe PI (19) . For annexin V and PI double staining, cells were suspended with 100 μl of binding buffer (10 mM N-2-hydroxyethylpiperazine-N′-2-ethanesulfonic acid/NaOH, 140 mM NaCl, 2.5 mM CaCl 2 , pH 7.4) and stained with 5 μl of FITC-conjugated annexin V and 5 μl of PI (50 μg/ml). The mixture was incubated for 15 min at room temperature in dark place and analyzed by the fluorescence-activated cell sorting cater-plus flow cytometry (Becton Dickinson Co.).
Western blot analysis
For total cell protein extracts, CWJ-082-treated cells were washed with ice-cold PBS and extracted in protein lysis buffer (Intron, Seoul, Korea). Protein concentration was determined by Bradford assay. Protein samples of cell lysate were mixed with an equal volume of 5× sodium dodecyl sulfate sample buffer, boiled for 4 min and then separated by 6-15% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gels. After electrophoresis, proteins were transferred to polyvinylidene difluoride membrane. The membranes were blocked in 5% non-fat dry milk for 1 h, rinsed and incubated with specific antibodies in Tris-buffered saline containing Tween-20 (0.1%) overnight at 4°C. Primary antibody was removed by washing the membranes three times in Tris-buffered saline containing Tween-20 and incubated for 1 h with horseradish peroxidase-conjugated secondary antibody (1:1000-2000). Following three times of washing in Trisbuffered saline containing Tween-20, immunopositive bands were visualized by enhanced chemiluminescence and exposed to X-ray film (Amersham, Piscataway, NJ).
Extraction of soluble and insoluble tubulin
After treatment with the CWJ-082, cells were washed twice with PBS, suspended in 400 μl monomeric extraction buffer [20 mM piperazine-N,N′-bis(2-ethanesulfonic acid) (pH 6.8), 0.14 M NaCl, 1 mM MgCl 2 , 1 mM ethyleneglycol-bis(aminoethylether)-tetraacetic acid, 0.5% NP-40, 0.5 mM phenylmethylsulfonylfluoride and 4 mM taxol], transferred to an Eppendorf tube and centrifuged at 13 000g for 10 min at room temperature. The NP-40-soluble extract contains monomeric tubulin. The supernatant was transferred to a new tube, and polymeric tubulin was extracted from the remaining insoluble materials using 0.4 ml radioimmunoprecipitation assay (RIPA) buffer [10 mM Tris (pH 7.4), 0.15 M NaCl, 1% deoxycholate, 1% NP-40 and 0.1% sodium dodecyl sulfate]. Total protein was measured in the monomeric fraction, and the polymeric fraction was determined after solubilization in RIPA buffer according to the manufacturer's instructions. The polymeric and monomeric fractions were separated by 10% SDS-PAGE gel electrophoresis, and the tubulin expression was analyzed by western blot analysis.
Immunoprecipitation
Cells were lysed in RIPA buffer containing 1 mM phenylmethylsulfonylfluoride and 1× protein inhibitor cocktail by sonication. After removal of debris and preclearing, 2 μl of antibodies was added and, 2 h later, 20 μl of PureProteome™ protein G magnetic beads (Millipore) was also added. After 30 min of rotation, beads were collected using a magnetic separation rack and then washed four times with RIPA buffer. Bound proteins were separated by 12% SDS-PAGE gel electrophoresis and then analyzed by western blot analysis.
Transfections
The small interfering RNA (siRNA) was synthesized by Bioneer Co. (Daejeon, Seoul, Korea). Cells were plated at a density of 0.5 × 10 5 per 35 mm dish 1 day before transfection. siRNA was transfected into the cells using Lipofectamine™ RNAiMAX (Invitrogen, Carlsbad, CA) at a final concentration of 0.1 μmol/l for 48 h. After transfection, the medium was replaced with fresh medium, and the cells were treated with CWJ-082. The sequences targeted by BubR1 or Mad2 siRNA were 5′-CACTTATGGTACTGTATAT-3′ and 5′-CTACTACAATCCACAAA-GT-3′, respectively. Cellular expression of BubR1 and Mad2 was examined by western blot analysis at 48 h after siRNA transfection.
Immunofluorescence staining and confocal microscopy Cells seeded on glass coverslips were incubated for 24 h at 37°C with or without CWJ-082, washed twice with PBS and fixed in situ with 90% methanol at 37°C for 30 min. The cells were again washed three times with PBS and blocked in 10% normal goat serum [in PBS containing Triton-X (0.3%)] for 1 h and incubated with anti-α-tubulin antibody (1:200, Santa Cruz Biotechnology) overnight at 4°C. Primary antibody was removed by washing the membranes three times in PBS containing Triton-X (0.3%) and incubated for 1 h with Alexa 488-conjugated anti-mouse secondary antibody (Molecular Probes, Eugene, OR, 1:200). Fluorescent signals were imaged using a confocal laser scanning microscope (Zeiss LSM 510, Carl Zeiss, Thornwood, NJ).
In vivo tumor xenograft studies
HeLa cells (2.5 × 10 6 per site) were injected subcutaneously into female BALB/c nude mice. Tumor size was measured using calipers every 3-4 days and calculated as V = π/6 × (length) × (width) 2 (20) . When tumors reached a volume of ~100-150 mm 3 , drug treatment was initiated. The control group was treated with vehicle (EtOH:Cremophor:DW = 1:1:18). During the treatment, tumor size and body weights were measured two times per week.
Statistical analysis
Data presented are the means ± SD of results from three independent experiments with similar patterns. Statistically significant values were compared using analysis of variance and Dunnett's post hoc test, and *P < 0.05, **P < 0.01 and ***P < 0.001 versus control group and # P < 0.05, ## P < 0.01 and ### P < 0.001 versus CWJ-082-treated group were considered statistically significant.
Results
CWJ-082-induced cell cycle arrest and caspase-dependent apoptosis in HeLa cells
To examine the effects of CWJ-082 on the viabilities of various cancer cells and normal cells, we assessed its effects using IC 50 values determined using MTT assay. CWJ-082 was found to have a cytotoxic effects on human ectocervical epithelial cell (IC 50 : 0.46 μM), human ovarian adenocarcinoma A2780 (IC 50 : 0.25 μM), human lung adenocarcinoma A549 (IC 50 : 9.67 μM), human glioblastoma A172 (IC 50 : 28.14) and to have marked cytotoxic effects on human cervical cancer cell lines, including HeLa (IC 50 : 0.19 μM) and Caski (IC 50 : 0.30 μM). Because CWJ-082 inhibited cancer cell growth, we analyzed its effect on cell cycles. HeLa and Caski cells were treated with CWJ-082 at various concentrations for different times, and then the DNA content of cells was analyzed using PI by a flow cytometry. CWJ-082 treatment led to notable accumulation of G 2 /M phase cells and a concomitant decrease of cells in the G 1 phase (Figure 1B) . The sub-G 1 phase cells, which represent apoptotic cell death, also increased in a time-and concentration-dependent manner in HeLa and Caski cells ( Figure 1B) . To investigate further whether CWJ-082-arrested cells underwent apoptosis, we examined treatment with CWJ-082 led to the activations of caspases in HeLa cells. Accordingly, cells were treated with serial concentrations of CWJ-082 for 48 h and then the enzymatic activities of caspase-3, -8 and -9 were examined. As shown in Figure 1C , CWJ-082 increased the activities of caspase-3, -8 and -9 significantly and in a concentration-dependent manner. To confirm the involvement of caspases in CWJ-082-induced apoptosis, HeLa cells were pretreated with z-VAD-fmk (a broad caspase inhibitor) for 1 h and then treated with CWJ-082 for 48 h. As shown in Figure 1D , z-VAD-fmk significantly suppressed CWJ-082-induced apoptosis in HeLa cells. Furthermore, western blot analysis also revealed that CWJ-082 triggered the phosphorylation of Bcl-2 (inactivating this protein) and increased PARP-1 cleavage in a time-dependent manner ( Figure 1E ). Taken together, these results indicate that CWJ-082-arrested cells undergo caspase-dependent apoptosis.
CWJ-082 induced mitotic cell accumulation in HeLa cells
In mammalian cells, the G 2 /M transition is triggered by regulation of cyclin B1 and CDK1, which promote the breakdown of the nuclear membrane, chromatin concentration and microtubule spindle formation (21) . Because CWJ-082 arrested G 2 /M phase in HeLa and Caski cells, the levels of cell cycle regulatory proteins in G 2 /M phase were examined by western blot analysis. As shown in Figure 2A , CWJ-082 caused an increase in the protein levels of cyclin B1 and induced the activation of CDK1 by phosphorylating Thr161 and dephosphorylating Tyr15 at 24 h, suggesting that it induced the activation of cyclin B1/CDK1 complex. These findings indicate that CWJ-082-treated cells entered mitosis and were then arrested in the mitotic phase. Furthermore, phase contrast microscopy showed that cells treated with CWJ-082 (300 nM) were rounder (a characteristic of mitotic phase arrest) (22) than control cells ( Figure 2B, upper panel) . In order to determine whether CWJ-082-treated cells were blocked at the mitotic phase, cells were stained with immunofluorescent antibody to p-histone H3 (a mitotic marker) and PI and analyzed by flow cytometry; mitotic cells were differentiated from G 2 cells by the level of p-histone H3 ( Figure 2B, lower panel) . Furthermore, treatment with CWJ-082 (300 nM) induced a time-dependent increase in the percentage of mitotic cells from 3.38% at 0 h to 37.41% at 24 h ( Figure 2C ). These results indicate that CWJ-082 induced a significant accumulation of mitotic cells and that these mitotic cells were arrested in prolonged mitosis.
CWJ-082 induced the activation of the SAC and the formation of the inhibitory complex of Mad with CDC20 in HeLa cells
The SAC controls the fidelity of chromosome segregation during mitosis and facilitates proper mitotic exit (23, 24) . Mad2, CDC20 and BubR1 are key components of the spindle checkpoint machinery, which ensures proper biorientation and attachment of sister chromosomes to kinetochores at the metaphase plate (25) . Since depletions of Mad2 and BubR1 have been reported to impair spindle checkpoint function, we used western blot analysis to determine whether CWJ-082 regulates the expressions of Mad2 and BubR1. Treatment with CWJ-082 markedly increased the phosphorylation of BubR1 from 4 h until 24 h, but protein levels of Mad2 and CDC20 remained unchanged at 24 h ( Figure 3A) . It is noteworthy that BubR1 protein was undetectable after 36 h CWJ-082 treatment in HeLa cells ( Figure 3A) . At 24 and 48 h after treatment with CWJ-082, a significant decline in the percentage of G 2 /M-arrested cells was observed with a corresponding increase in the percentage of apoptotic cells (Supplementary Figure 1 , available at Carcinogenesis Online). Since cyclin B1 is degraded by proteasome in a cell cycle-dependent manner after APC/C-dependent ubiquitination, the accumulation of cyclin B1 would imply that its degradation pathway is blocked by CWJ-082. Therefore, we decided to examine whether CWJ-082 inhibits APC/C-dependent activity. APC/C-dependent ubiquitination is dependent on the substrate recognition protein CDC20 (mammalian homologue p55CDC), which is associated with its inhibitory protein Mad2 (25) . Therefore, we examined the formation of the inhibitory complex of CDC20 with Mad2 at different times after treating HeLa cells with CWJ-082 ( Figure 3B ). As was expected, CWJ-082 induced an association between CDC20 and the inhibitory protein Mad2, which peaked at 8 h. Furthermore, this inhibitory complex may block APC/C-dependent cyclin B1 degradation (26) . Taken together, these findings suggest that CWJ-082 caused cell cycle arrest at the mitotic phase by activating BubR1 and facilitating the formation of the Mad2/CDC20 inhibitory checkpoint complex in HeLa cells. To further investigate the roles of BubR1 and Mad2 in CWJ-082-induced mitotic arrest and apoptosis, endogenous levels of BubR1 or Mad2 were reduced by RNA interference. Transfection of cells with BubR1-or Mad2-specific siRNAs considerably reduced the expressions levels of BubR1 and Mad2 (Supplementary Figure 2A , available at Carcinogenesis Online). When cells were examined by phase contrast microscopy, CWJ-082-induced cells transfected with 10 nM of control siRNA exhibited a round morphology and apoptotic bodies, indicating they were mitotic or apoptotic (Supplementary Figure 1B , available at Carcinogenesis Online). Interestingly, the downregulation of Mad2 significantly inhibited mitotic cell accumulation, apoptotic cell death and the cleavage of PARP in CWJ-082-treated cells ( Figure 3C-E) , whereas suppression of BubR1 by siRNA interference showed significant but less inhibitory effects than Mad2-specific siRNA. Taken together, these findings suggest that Mad2 and BubR1 are involved in CWJ-082-induced mitotic cell accumulation and apoptosis in HeLa cells.
CWJ-082 increased microtubule polymerization by increasing polymeric α-tubulin in HeLa cells
Immunocytochemical analysis was conducted to determine whether CWJ-082-mediated attenuations of cell cycle and SAC proteins affected microtubules. As shown in Figure 4A , CWJ-082 promoted the maintenance of microtubule polymerization and increased microtubule density, and paclitaxel (a microtubule polymerizing agent) had a similar effect, whereas nocodazole inhibited microtubule polymerization and short microtubule fragments were observed in cytoplasm. Since tubulin dimer, which consists of α-and β-subunits, polymerizes to form insoluble microtubule polymers during mitosis, analysis of soluble and insoluble fractions allows contents of soluble unpolymerized tubulin and insoluble microtubules to be determined (3) . As shown in Figure 4B , densitometric analysis of soluble α-tubulin normalized versus β-actin after treatment with CWJ-082 revealed a marked timedependent decrease and a commensurate marked increase in insoluble α-tubulin. These observations indicate that CWJ-082, like paclitaxel, promotes microtubule polymerization in HeLa cells. Figure 5A ). In addition, the mortality rate in the CWJ-082-treated or vehicle-treated group was zero during the experimental period, which supports the low toxicity of CWJ-082 (data not shown). Tumor volumes after treatment with CWJ-082 or paclitaxel from days 18 to 28 were significantly less than those of the vehicle-treated control ( Figure 5B ). Representative tumor weights in HeLa xenograft mice treated with or without CWJ-082 are shown in Figure 5C . As compared with vehicle-treated control, CWJ-082 significantly decreased tumor weights by 23.1, 50.0 and 57.7% at 2.5, 5.0 and 10.0 mg/kg, respectively. Furthermore, histone H3 phosphorylation and PARP cleavage were observed in tumors of xenograft mice administered with CWJ-082 or paclitaxel ( Figure 5D ). These findings indicate that the antitumor activity of CWJ-082 involves the induction of mitotic arrest and apoptosis in our BALB/c nu/nu mouse HeLa xenograft model.
CWJ-082 inhibited tumor growth via apoptosis in a xenograft model
Discussion
During our continued efforts to develop potent antitumor agents, we investigated the synthesis, biological evaluation and quantitative structure-activity relationships of 3-arylisoquinoline compounds, such as indeno [1,2-c] isoquinolines (27) (29) . Our recent studies have shown that CWJ-082 is potently cytotoxic to various cancer cells and that it effectively induces the apoptosis of HeLa human cervical cancer cells (17) . In the present study, we identify the molecular mechanisms responsible for CWJ-082-induced apoptosis: (i) CWJ-082 arrests proliferating cervical cancer cells in the mitotic phase; (ii) CWJ-082 regulates the SAC and induces mitotic cell accumulation followed by apoptosis, which suggests that CWJ-082 induces mitotic arrest and cell death mainly via Mad2; (iii) CWJ-082 promotes tubulin polymerization, which is critically required for cell division and (iv) CWJ-082 inhibits tumor growth in BALB/c nu/nu mice bearing a HeLa xenograft. Taken together, CWJ-082 exerts its strong anticancer effects against cervical cancer cells by promoting tubulin polymerization and then disrupting organization of the microtubule cytoskeleton.
Cell cycle checkpoints are crucial events in which numerous pathways control whether cells undergo DNA repair, apoptosis or differentiation (30, 31) . CDK1 and cyclin B play regulatory key roles as the activation of CDK1/cyclin B1 complex in the nucleus triggers cell cycle progression from the G 2 phase to the M phase (32) . Numerous factors regulate CDK1 activity, including cyclin B1, the phosphorylation of different CDK1 residues, the CDK1 inhibitor p21
Cip1/Waf1 and Cdc25 phosphatase (33) . The activation of CDK1 depends on its phosphorylation at Thr161 and dephosphorylation at Tyr15 (34,35) . In the present study, CWJ-082-induced G 2 /M cell cycle arrest in HeLa The expression levels of proteins were determined by western blotting using β-actin as the internal control. Relative intensities of p-CDK (Thr161, Tyr15) and cyclin B1 bands were normalized versus β-actin. Experiments were repeated three times and similar results were obtained. Densitometric analysis was performed using Bio-Rad Quantity One® Software. (B) HeLa cells were treated with CWJ-082 (300 nM) for 24 h, and cell morphologies were examined by phase contrast microscopy (original magnification ×400, upper panel). Representative flow cytometry data for untreated and CWJ-082-treated cells (300 nM for 24 h) stained with an antibody against p-histone H3; the present mitotic cells are shown near the rectangles (lower panel). (C) HeLa cells were treated with or without CWJ-082 (300 nM) for the indicated times. Mitotic cells were stained with an antibody against p-histone H3 and analyzed by flow cytometry. The data shown represent means ± SD of three independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001 versus control group. 300 nM for 48 h) . Levels of proteins were determined by western was found to be associated with this phosphorylation and dephosphorylation of CDK1. To confirm whether CWJ-082-treated cells were arrested at G 2 or at the mitotic phase, we analyzed cells stained with p-histone H3 (a mitotic marker) and PI by flow cytometry. It was found that 37.41% of cells were positively stained with this antibody at 24 h after CWJ-082 treatment, indicating an accumulation of mitotic cells.
In order to delineate the mechanisms that may be involved in the mitotic arrest of HeLa cells induced by CWJ-082, we examined mitotic checkpoint components, namely, Mad2, BubR1 and CDC20. First, we examined the mitotic spindle checkpoint protein BubR1, which monitors tension across attached kinetochores and initiates mitotic arrest in response to loss of microtubule tension (22) . DNA content analysis data demonstrated that HeLa cells remained in G 2 /M for a sustained period, some cells remained in arrested after 24 h, and therefore, we decided to investigate whether BubR1 was associated with this sustained arrest. Indeed, we found that initially BubR1 was hyperphosphorylated (indicative of an active mitotic checkpoint) (23) in HeLa cells treated with CWJ-082. Subsequently, the expression of BubR1 declined in concert with a decrease in the number of cells undergoing G 2 /M arrest and an increase in apoptosis and indicating that the phosphorylation status of BubR1 in Hela cells is directly related to G 2 /M arrest. Therefore, we postulate that the phosphorylation of BubR1 in HeLa cells is likely to have contributed to the sustained arrest observed. In addition, CDC20, an activator and substrate adaptor for the ubiquitin ligase APC/C, plays a key role in metaphase-to-anaphase transition. Under circumstances of chromosome misalignment, CDC20 is inhibited by proteins, including Mad2, and as a result entry into anaphase is delayed. Furthermore, after chromosomal alignment has been corrected, activated CDC20 in turn activates APC/C to trigger polyubiquitination and proteasomal degradation of substrates, which include securin and cyclin B. The present study shows that CWJ-082 induced an association between CDC20 and the inhibitory protein Mad2 for 8 h. In parallel with CDC20 to Mad2 binding, CWJ-082 caused a time-dependent accumulation of APC/C-dependent cyclin B1. Since the suppression of spindle checkpoint function reduces taxol-or nocodazole-induced mitotic arrest and apoptosis (36, 37) , we next sought to determine, using a RNA interference strategy, whether the forced downregulation of Mad2 or BubR1 could induce a similar phenotype in terms of mitotic arrest and apoptotic susceptibility to CWJ-082. Gene silencing of Mad2 or BubR1 significantly reduced CWJ-082-induced mitotic cell accumulation and apoptosis in HeLa cells. These results show that CWJ-082-induced mitotic cell accumulation and apoptosis are dependent on the cellular checkpoint function of Mad2/BuBR1, which begs the question as to how CWJ-082 induces the inhibitory complex of CDC20/Mad2 and the phosphorylation of BubR1.
The majority of microtubule-targeting antitumor compounds has been discovered by the large-scale screening of natural products and either stabilize or destabilize microtubule polymerization (38) . For instance, taxane stabilize microtubules, whereas vinca alkaloid derivatives and colchicine destabilize microtubules. Because these microtubule poisons cause all kinetochores to become unattached, thereby generating a mitotic checkpoint signal, we decided to examine whether CWJ-082 affects dynamic dysfunction of microtubule structure. CWJ-082 treatment was found to result in microtubule polymerization and to increase in the density of cellular microtubules as compared with control cells. Thus, we concluded that the promotion of tubulin polymerization by CWJ-082 caused cells to arrest in the M phase, thereby blocking cell cycle progression, which is similar to the mode of action of paclitaxel (39) .
Mitotic catastrophe is defined as a type of cell death that occurs during, or shortly after, dysregulated or failed mitosis (40) . Depending on genetic background and growth conditions, mitotic catastrophe can have different endpoints, which include apoptosis, senescence and necrosis (41) . In this study, we attempted to characterize the apoptotic action of CWJ-082. After treatment with CWJ-082, intense G 2 /M arrest was characterized by a loss of cell cycle checkpoint proteins and blotting. The relative intensities of cleaved PARP-1 bands were normalized versus β-actin. Experiments were repeated three times and similar results were obtained. Densitometric analysis was performed using Bio-Rad Quantity One® Software. The data shown represent means ± SD of three independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001 versus control group and ← mitotic spindle checkpoint proteins; the cells then entered apoptosis, with the emergence of the sub-G 1 cell population following the corresponding collapse of G 2 /M accumulation in flow cytometric analyses and with cleaved forms of PARP detected in western blot analysis. In addition, CWJ-082 was found to activate caspase-8, caspase-9 and the downstream caspase-3 and lead to PARP cleavage. Furthermore, a broad caspase inhibitor was found to suppress CWJ-082-induced apoptosis. These findings indicated that caspase-activating intrinsic and extrinsic apoptotic cascades are involved after CWJ-082-induced mitotic catastrophe. Increased CDK1 activity has been observed under a variety of apoptotic conditions (42) , and the inhibition of CDK1 activity has been reported to block paclitaxel-induced mitotic death (43) . Thus, it is possible that increased CDK1 activity due to the CWJ-082-induced expression of cyclin B and increased CDK1 Thr161 phosphorylation coupled with reduced Tyr15 phosphorylation leads to the initiation of apoptosis. Consistent with this hypothesis, in a previous report, it was found that CDK1 could phosphorylate Bcl-2 at Ser70 and Ser87 and suppress its antiapoptotic function (44) . In the present study, CWJ-082 increased Ser70 phosphorylation of Bcl-2, suggesting that Bcl-2 is a possible substrate of CDK1. Our results suggest the possibility that the inappropriate CWJ-082-induced hyperactivity of CDK1 resulted in apoptosis due to Bcl-2 phosphorylation at Ser70. Tumor tissues obtained on treatment day 28 were lysed and western blotted. Protein levels were determined by western blotting with anti-p-histone H3, anti-PARP-1 or anti-β-actin. The relative intensities of p-histone H3 and cleaved PARP-1 bands were normalized versus β-actin. Experiments were repeated three times and similar results were obtained. Densitometric analysis was performed using Bio-Rad Quantity One® Software. The data shown represent means ± SD of three independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001 versus vehicle-treated control group.
Based on the inductions of mitotic arrest and apoptosis by CWJ-082 in HeLa cell, we examined its in vivo effects. In our BALB/c nu/nu mouse xenograft model, CWJ-082 (2.5, 5 or 10 mg/kg/day, intraperitoneally) was found to significantly reduce tumor volumes and tumor weights from treatment day 18 versus vehicle-treated control. Furthermore, CWJ-082 treatment was well tolerated after being administered for 28 days at 2.5, 5 or 10 mg/kg/day, and the body weights of HeLa xenograft mice were not significantly affected. Based on our observations of mitotic arrest and apoptosis by CWJ-082 in vitro, we examined histone H3 phosphorylation and PARP-1 cleavage by western blotting in tumor lysates. Both were detected in CWJ-082-and paclitaxel-treated animals but not in vehicle-treated control. Accordingly, our results support mitotic arrest and apoptosis in CWJ-082-treated HeLa xenograft mice.
Taken together, these findings suggest that CWJ-082 cause tubulin polymerization, leading to SAC activation, and mitotic arrest of cell cycle, and that this triggers apoptosis in HeLa cells. Moreover, CWJ-082 decreased tumor growth in our in vivo study of HeLa xenograft mice. These novel biological properties of CWJ-082 make it an attractive candidate for the further development of novel agents for the treatment of human cervical cancer. 
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